ProShare Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

ProShare Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,090	Closed	-$583K	–	2273
2020 Q4	$583K	Buy	8,090 +3,361	+71%	+$176K	﹤0.01%	1164
2020 Q3	$216K	Sell	4,729 -405	-8%	-$16.9K	﹤0.01%	1380
2020 Q2	$232K	Buy	+5,134	New	+$230K	﹤0.01%	1376
2020 Q1	–	Sell	-5,433	Closed	-$252K	–	1775
2019 Q4	$252K	Buy	+5,433	New	+$235K	﹤0.01%	1448
2019 Q3	–	Sell	-4,467	Closed	-$215K	–	1725
2019 Q2	$215K	Sell	4,467 -84	-2%	-$4.42K	﹤0.01%	1404
2019 Q1	$285K	Buy	4,551 +153	+3%	+$10.5K	﹤0.01%	1282
2018 Q4	$263K	Sell	4,398 -400	-8%	-$24K	﹤0.01%	1223
2018 Q3	$309K	Sell	4,798 -483	-9%	-$27K	﹤0.01%	1340
2018 Q2	$238K	Buy	+5,281	New	+$211K	﹤0.01%	1516
2014 Q4	–	Sell	-10,439	Closed	-$70K	–	2327
2014 Q3	$70K	Sell	10,439 -2,359	-18%	-$16.5K	﹤0.01%	2226
2014 Q2	$92K	Buy	+12,798	New	+$102K	﹤0.01%	2383

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

ProShare Advisors's BEAT Position: Q1 2021 in Review

ProShare Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 8,090 shares — an estimated $583K sold.

ProShare Advisors first reported a position in BEAT in Q2 2014 and held it in 11 quarters. The position peaked at $583K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

ProShare Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
ProShare Advisors sold 8,090 BioTelemetry, Inc. shares in Q1 2021, an estimated $583K.
ProShare Advisors first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 11 quarters.
ProShare Advisors's BioTelemetry, Inc. position peaked at $583K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on ProShare Advisors's 13F filing for Q1 2021, filed 14 May 2021.